Apr 01, 2022/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Canine Flu Therapeutics Market.

It was estimated prior to this unanticipated outbreak that the Canine Flu Therapeutics Market is expected to register an overall rebounding Healthy CAGR during the forecast period. Canine flu also referred to as dog flu, is a contagious disease that affects the dog’s respiratory system. It is primarily caused by the canine influenza virus or type A influenza virus. The flu consists of two types of influenza viruses H3N8 and the H3N2 virus. The symptoms of this disease include reduced appetite, upper respiratory illness, cough, eye discharges, runny nose, fever, and lethargy. The severity of the flu can range from dogs with no symptoms to terminal illness which can lead to pneumonia and finally death.

For a more detailed breakdown of the COVID-19 impact on the Canine Flu Therapeutics Market, request a free sample of the report here:

https://www.stratviewresearch.com/Request-Sample/1805/canine-flu-therapeutics-market.html#form

Market Dynamics

Dogs are highly vulnerable to canine flu if they come in contact with the respiratory flow/discharges of the infected canines. As per the study by the Wisconsin University, the H3N2 virus retains its existence for a longer period of time when compared to the H3N8 virus, which leads to the spread of canine flu in other dogs resulting in multiple outbreaks. Dogs with canine flu cannot be easily identified, and so these dogs need protection. Moreover, there is no specific treatment for the disease thus stresses on the veterinary society to discover new drugs, which in turn augments the product demand.

COVID-19 Impact on Global Canine Flu Therapeutics Market

The COVID-19 pandemic has positively influenced the Canine Flu Therapeutics industry. Condoms have experienced a surge, whereas the demand for sex toys and other items witnessed a temporary decline. However, to attend to their sexual needs due to the limited movement of people with partners staying in different homes, people have started relying on vibrators and other sex toys to cater to their sexual pleasure. Governments around the world have issued advisories to encourage safe sex with partners during the lockdown.

Click here for ToC of the report:

https://www.stratviewresearch.com/toc/1805/canine-flu-therapeutics-market.html

Segment Analysis

By type, the canine flu therapeutics market has been segmented into vaccines, antibiotics, anti-inflammatory drugs, and others. Under these, the vaccines segment accounted for the largest market share in 2020 and is projected to register a healthy CAGR in the following years. Vaccination against canine flu influenza can significantly reduce the risk of the dog contracting the canine influenza virus, thus reduces the exposure, which bolsters the segment growth.

By region, the market in North America garnered the highest market share in 2020 and is projected to grow at a steady CAGR during the assessment period. This is mainly attributed to improvisation and development in the sex toys and condoms, rising LGBTQ+ population, increasing awareness of STDs and HIV infections, and increasing liberalization and experimentation of sexuality among the people, which further augments the regional growth.

North America dominant in the Global canine flu therapeutic market mainly due to the high penetration. In North America, particularly the USA is dominating due to the high adoption of treatment method to the canine flu.

Key Players:

Key players operating in the global Canine Flu Therapeutics market are-

  • Merck Animal Health (The US),
  • GlaxoSmithKline (UK),
  • Pfizer (The U.S),
  • Zoetis (The U.S),
  • Novartis (Switzerland),
  • Sanofi (France),
  • Boehringer Ingelheim International (Germany),
  • Bristol-Myers Squibb (The U.S),
  • Roche (Switzerland),
  • Eli Lilly and Company (The U.S),
  • Abbott Laboratories (The U.S).

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The Canine Flu Therapeutics analysis report discusses the following heads in great detail:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis
  • COVID-19 Impact Assessment
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
  • Attractive market segments and associated growth opportunities
  • Emerging trends
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Know more about Stratview Research:

Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.

Need a detailed report? Get in touch with us: 

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176